- Home
- CDNA vs TPB Comparison
CDNA vs TPB Comparison
Compare CDNA & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- TPB
- Stock Information
- Founded
- CDNA 1998
- TPB 1988
- Country
- CDNA United States
- TPB United States
- Employees
- CDNA N/A
- TPB N/A
- Industry
- CDNA Medical Specialities
- TPB Tobacco
- Sector
- CDNA Health Care
- TPB Consumer Discretionary
- Exchange
- CDNA Nasdaq
- TPB Nasdaq
- Market Cap
- CDNA 712.2M
- TPB 1.8B
- IPO Year
- CDNA 2014
- TPB 2016
- Fundamental
- Price
- CDNA $14.77
- TPB $102.33
- Analyst Decision
- CDNA Buy
- TPB Strong Buy
- Analyst Count
- CDNA 8
- TPB 5
- Target Price
- CDNA $26.86
- TPB $77.00
- AVG Volume (30 Days)
- CDNA 1.5M
- TPB 311.4K
- Earning Date
- CDNA 11-03-2025
- TPB 11-06-2025
- Dividend Yield
- CDNA N/A
- TPB 0.30%
- EPS Growth
- CDNA N/A
- TPB N/A
- EPS
- CDNA 1.00
- TPB N/A
- Revenue
- CDNA $340,826,000.00
- TPB $407,441,000.00
- Revenue This Year
- CDNA $13.02
- TPB $25.18
- Revenue Next Year
- CDNA $12.85
- TPB $9.03
- P/E Ratio
- CDNA $14.21
- TPB N/A
- Revenue Growth
- CDNA 14.72
- TPB 37.09
- 52 Week Low
- CDNA $10.96
- TPB $38.64
- 52 Week High
- CDNA $32.97
- TPB $104.76
- Technical
- Relative Strength Index (RSI)
- CDNA 62.94
- TPB 64.11
- Support Level
- CDNA $13.23
- TPB $100.47
- Resistance Level
- CDNA $13.80
- TPB $104.25
- Average True Range (ATR)
- CDNA 0.68
- TPB 3.15
- MACD
- CDNA 0.21
- TPB -0.30
- Stochastic Oscillator
- CDNA 95.71
- TPB 73.43
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.